-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HwCcfMxr71XrQgUj2m0KdADm91EUeFRYAnoSbsddTpwZ4Lwlq1aEId4BXbhT8Zm1 7b8OFPRi/yIaIAq9K7n9MA== 0001144204-08-032506.txt : 20080528 0001144204-08-032506.hdr.sgml : 20080528 20080528172416 ACCESSION NUMBER: 0001144204-08-032506 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080528 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20080528 DATE AS OF CHANGE: 20080528 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHINA SKY ONE MEDICAL, INC. CENTRAL INDEX KEY: 0000798985 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870430322 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34080 FILM NUMBER: 08864355 BUSINESS ADDRESS: STREET 1: NO. 38 DINGXIN 3RD STREET STREET 2: NANGANG DISTRICT, HEILONGJIANG PROVINCE CITY: HARBIN STATE: F4 ZIP: 150001 BUSINESS PHONE: 213-488-5131 MAIL ADDRESS: STREET 1: 865 SO. FIGUEROA ST STREET 2: SUITE 3340-C CITY: LOS ANGELES STATE: CA ZIP: 90017 FORMER COMPANY: FORMER CONFORMED NAME: COMET TECHNOLOGIES INC DATE OF NAME CHANGE: 19990510 8-K 1 v115979_8k.htm Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 

 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported):
 May 28, 2008
 
CHINA SKY ONE MEDICAL, INC.
(Exact Name of Registrant as Specified in Charter)
 
Nevada
 
000-26059
 
87-0430322
(State or Other Jurisdiction
of Incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
Room 1706, No. 30 Di Wang Building, Gan Shui Road,
Nandang District, Harbin, People’s Republic of China 150001
(Address of Principal Executive Offices)
 
Registrant's telephone number, including area code:
86-451-53994073 (China)
 
 
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 


Item 7.01
Regulation FD Disclosure

On May 28, 2008, China Sky One Medical, Inc. (the “Company”) distributed a press release announcing the commencement of trading of the Company’s common shares on the American Stock Exchange (AMEX). A copy of this press release is furnished as an exhibit to this report.

Item 8.01
Other Events.

On May 28, 2008, the Company’s common shares have commenced trading on the AMEX under the trading symbol of “CSY”. The Company intends that quotations for the common shares on the OTC Bulletin Board will cease.

Item 9.01.
Financial Statements and Exhibits
 
 
(d)
Exhibits.
 
The exhibits listed in the following Exhibit Index are furnished as part of this Current Report on Form 8-K.
 
Exhibit No.
 
Description
99.1
 
Press Release, dated March 28, 2008, relating to commencement of trading of Common Shares of China Sky One Medical, Inc. on the American Stock Exchange.  



SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
 
CHINA SKY ONE MEDICAL, INC.

 
 
 
(Registrant) 
Date:       May 28, 2008                                                                           By:   /s/ Liu Yan Qing
 
Liu Yan Qing
 
Chairman, Chief Executive Officer and President
 

 
EX-99.1 2 v115979_ex99-1.htm Unassociated Document
 
Company Contact:  
Investor Relations Contact:
China Sky One Medical, Inc.
CCG Elite Investor Relations Inc.
Mr. Liao Xiaoqing, CFO
Mr. Crocker Coulson, President
Phone: 86-1591-067-2198
Phone: +1-646-213-1915 (New York)
Email:tdrhan@163.com
Email: crocker.coulson@ccgir.com
 
Website: www.ccgelite.com
 
 
FOR IMMEDIATE RELEASE
China Sky One Medical, Inc. Commences
 
Trading on the American Stock Exchange

HARBIN, China, May 28, 2008 -- China Sky One Medical, Inc. (AMEX: CSY) (“China Sky One Medical” or “the Company”), a manufacturer, marketer and distributor of pharmaceutical, medicinal and diagnostic products in China, today announced today that its common shares began trading on the American Stock Exchange (“AMEX”) under the symbol "CSY." Previously, the Company was quoted on the Over-the-Counter Bulletin Board under the symbol “CSKI.”
 
"We are pleased to be listed on AMEX," said Mr. Yanqin Liu, Chairman and Chief Executive Officer of China Sky One Medical. "AMEX provides a broader investor base, which will better reflect the Company’s true valuation. We look forward to continuing to deliver outstanding returns for our shareholders."
 
About China Sky One Medical, Inc.
 
China Sky One Medical, Inc., a Nevada corporation, is a holding company whose principal operations are through its subsidiaries, which are engaged in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic kit products. Through its wholly-owned PRC based subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company Harbin First Bio- Engineering Company Limited and Heilongjiang Tianlong Pharmaceutical, Inc., the Company manufactures and distributes over-the- counter pharmaceutical products as its primary revenue source. For more information, visit http://www.skyonemedical.com.
 
Safe Harbor Statement
 
Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding our future plans, objectives or performance. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.
 
###
 

-----END PRIVACY-ENHANCED MESSAGE-----